1. a b Jukić T, et al. The use of a food supplementation with D-phenylalanine, L-glutamine and L-5-hydroxytriptophan in the alleviation of alcohol withdrawal symptomsColl Antropol. (2011)
  2. a b c Rondanelli M, et al. Satiety and amino-acid profile in overweight women after a new treatment using a natural plant extract sublingual spray formulationInt J Obes (Lond). (2009)
  3. a b c Rondanelli M, et al. Relationship between the absorption of 5-hydroxytryptophan from an integrated diet, by means of Griffonia simplicifolia extract, and the effect on satiety in overweight females after oral spray administrationEat Weight Disord. (2012)
  4. a b c Turner EH, Loftis JM, Blackwell AD. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophanPharmacol Ther. (2006)
  5. ^ Birdsall TC. 5-Hydroxytryptophan: a clinically-effective serotonin precursorAltern Med Rev. (1998)
  6. ^ The Metabolism of L-Tryptophan by Isolated Rat Liver Cells.
  7. a b Metabolism of an oral tryptophan load. I: Effects of dose and pretreatment with tryptophan.
  8. ^ O’Neil MF, Moore NA. Animal models of depression: are there anyHum Psychopharmacol. (2003)
  9. a b c d e Ceci F, et al. The effects of oral 5-hydroxytryptophan administration on feeding behavior in obese adult female subjectsJ Neural Transm. (1989)
  10. a b c d e f Cangiano C, et al. Effects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent diabetic patientsInt J Obes Relat Metab Disord. (1998)
  11. ^ Cangiano C, et al. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophanAm J Clin Nutr. (1992)
  12. ^ Cangiano C, et al. Effects of 5-hydroxytryptophan on eating behavior and adherence to dietary prescriptions in obese adult subjectsAdv Exp Med Biol. (1991)
  13. ^ Precursor control of Neurotransmitter Synthesis.
  14. ^ Wurtman RJ, Wurtman JJ. Brain serotonin, carbohydrate-craving, obesity and depressionObes Res. (1995)
  15. ^ Routh VH, Stern JS, Horwitz BA. Serotonergic activity is depressed in the ventromedial hypothalamic nucleus of 12-day-old obese Zucker ratsAm J Physiol. (1994)
  16. ^ Total and Free tryptophan concentration in the plasma of depressive patients.
  17. a b Decreased plasma tryptophan levels in major depression.
  18. a b Taylor MW, Feng GS. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolismFASEB J. (1991)
  19. ^ Myint AM, Kim YK. Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depressionMed Hypotheses. (2003)
  20. ^ Transcriptional activation of Indoleamine Dioxygenase by Interleukin 1 and Tumor Necrosis Factor α in Interferon-Treated Epithelial Cells.
  21. ^ The phenomenology and treatment of interferon-induced depression.
  22. ^ Bonaccorso S, et al. Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic systemJ Clin Psychopharmacol. (2002)
  23. ^ Shaw K, Turner J, Del Mar C. Are tryptophan and 5-hydroxytryptophan effective treatments for depression? A meta-analysisAust N Z J Psychiatry. (2002)
  24. ^ van Hiele LJ. l-5-Hydroxytryptophan in depression: the first substitution therapy in psychiatry? The treatment of 99 out-patients with ‘therapy-resistant’ depressionsNeuropsychobiology. (1980)
  25. a b c Hinz M, Stein A, Uncini T. 5-HTP efficacy and contraindicationsNeuropsychiatr Dis Treat. (2012)
  26. ^ Hinz M, Stein A, Uncini T. Amino acid management of Parkinson’s disease: a case studyInt J Gen Med. (2011)
  27. ^ Hinz M, Stein A, Uncini T. Monoamine depletion by reuptake inhibitorsDrug Healthc Patient Saf. (2011)
  28. ^ Shell W, et al. A randomized, placebo-controlled trial of an amino acid preparation on timing and quality of sleepAm J Ther. (2010)
  29. ^ Emanuele E, et al. An open-label trial of L-5-hydroxytryptophan in subjects with romantic stressNeuro Endocrinol Lett. (2010)
  30. ^ Speroff L, et al. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trialObstet Gynecol. (2008)
  31. ^ Stearns V, et al. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trialJ Clin Oncol. (2005)
  32. ^ Freedman RR. Treatment of menopausal hot flashes with 5-hydroxytryptophanMaturitas. (2010)
  33. ^ Freedman RR, Wasson S. Miniature hygrometric hot flash recorderFertil Steril. (2007)
  34. ^ Park SB, et al. Tryptophan depletion in normal volunteers produces selective impairments in learning and memoryNeuropharmacology. (1994)
  35. ^ Oldman A, et al. Biochemical and behavioural effects of acute tryptophan depletion in abstinent bulimic subjects: a pilot studyPsychol Med. (1995)
  36. ^ Cleare AJ, Bond AJ. The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjectsPsychopharmacology (Berl). (1995)
  37. ^ Klaassen T, et al. Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challengePsychiatry Res. (1998)
  38. ^ Miller HE, Deakin JF, Anderson IM. Effect of acute tryptophan depletion on CO2-induced anxiety in patients with panic disorder and normal volunteersBr J Psychiatry. (2000)
  39. ^ Schruers K, et al. Effects of tryptophan depletion on carbon dioxide provoked panic in panic disorder patientsPsychiatry Res. (2000)
  40. ^ Schruers K, et al. Acute L-5-hydroxytryptophan administration inhibits carbon dioxide-induced panic in panic disorder patientsPsychiatry Res. (2002)
  41. ^ Maron E, et al. The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteersJ Psychopharmacol. (2004)
  42. a b Bruni O, et al. L -5-Hydroxytryptophan treatment of sleep terrors in childrenEur J Pediatr. (2004)
  43. ^ Schruers K, et al. L-5-hydroxytryptophan induced increase in salivary cortisol in panic disorder patients and healthy volunteersPsychopharmacology (Berl). (2002)
  44. ^ Stamford JA, Kruk ZL, Millar J. Striatal dopamine terminals release serotonin after 5-HTP pretreatment: in vivo voltammetric dataBrain Res. (1990)
  45. a b Zhelyaskov DK, Levitt M, Udenfriend S. Tryptophan derivatives as inhibitors of tyrosine hydroxylase in vivo and in vitroMol Pharmacol. (1968)
  46. ^ Awazi N, Guldberg HC. On the interaction of 5-hydroxytryptophan and 5-hydroxytryptamine with dopamine metabolism in the rat striatumNaunyn Schmiedebergs Arch Pharmacol. (1978)
  47. ^ Breier JM, Bankson MG, Yamamoto BK. L-tyrosine contributes to (+)-3,4-methylenedioxymethamphetamine-induced serotonin depletionsJ Neurosci. (2006)
  48. a b Correlation between brain tryptophan and plasma neutral amino acid levels following food consumption in rats.
  49. ^ Ritvo ER, et al. Effects of L-dopa in autismJ Autism Child Schizophr. (1971)
  50. a b Karobath M, Díaz JL, Huttunen MO. The effect of L-dopa on the concentrations of tryptophan, tyrosine and serotonin in rat brainEur J Pharmacol. (1971)
  51. ^ Borah A, Mohanakumar KP. Long-term L-DOPA treatment causes indiscriminate increase in dopamine levels at the cost of serotonin synthesis in discrete brain regions of ratsCell Mol Neurobiol. (2007)
  52. ^ van Praag HM. In search of the mode of action of antidepressants. 5-HTP/tyrosine mixtures in depressionsNeuropharmacology. (1983)
  53. ^ Henman FD. Amino acid decarboxylase enzymes–vital or irrelevant to gastric secretionDigestion. (1975)
  54. a b Orlefors H, et al. Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomographyEur J Nucl Med Mol Imaging. (2006)
  55. ^ Bertoldi M, Gonsalvi M, Voltattorni CB. Green tea polyphenols: novel irreversible inhibitors of dopa decarboxylaseBiochem Biophys Res Commun. (2001)
  56. ^ Gustafsson BI, et al. Long-term serotonin administration induces heart valve disease in ratsCirculation. (2005)
  57. ^ Aliño JJ, Gutierrez JL, Iglesias ML. 5-Hydroxytryptophan (5-HTP) and a MAOI (nialamide) in the treatment of depressions. A double-blind controlled studyInt Pharmacopsychiatry. (1976)
  58. ^ Kline N, Sacks W. Treatment of depression with an mao inhibitor followed by 5-HTP–an unfinished research projectActa Psychiatr Scand Suppl. (1980)
  59. ^ Nicolodi M, Sicuteri F. Fibromyalgia and migraine, two faces of the same mechanism. Serotonin as the common clue for pathogenesis and therapyAdv Exp Med Biol. (1996)
  60. ^ Comparison of the Antidepressant Action of Tryptophan, Tryptophan/5-Hydroxytryptophan Combination and Nomifensine.
  61. ^ Nardini M, et al. Treatment of depression with L-5-hydroxytryptophan combined with chlorimipramine, a double-blind studyInt J Clin Pharmacol Res. (1983)
  62. ^ van der Horst-Schrivers AN, et al. Persistent low urinary excretion of 5-HIAA is a marker for favourable survival during follow-up in patients with disseminated midgut carcinoid tumoursEur J Cancer. (2007)
  63. a b Joy T, et al. Increase of urinary 5-hydroxyindoleacetic acid excretion but not serum chromogranin A following over-the-counter 5-hydroxytryptophan intakeCan J Gastroenterol. (2008)